Katerina Pavenski, Ian Quirt. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Cost-Benefit AnalysisDisease SusceptibilityHumansIron Chelating Agents/economicsIron Chelating Agents/therapeutic usePatient Compliance
Substances: See more » Iron Chelating Agents
Year: 2007 PMID: 17880597 DOI: 10.1111/j.1537-2995.2007.01460.x
Source DB: PubMed Journal: Transfusion ISSN: 0041-1132 Impact factor: 3.157